Ipilimumab and GMCSF Immunotherapy for Prostate Cancer
by on Friday, February 10th, 2012 | No Comments
Condition: Prostate Cancer
Interventions: Drug: Ipilimumab; Drug: Ipilimumab and GM-CSF
Sponsors: University of California, San Francisco; Bristol-Myers Squibb; Genzyme
Not yet recruiting – verified February 2012
Read more: Ipilimumab and GMCSF Immunotherapy for Prostate Cancer